Clinical evaluation of hydrocortisone valerate 0.2% ointment.
J Sefton, J S Loder, A A Kyriakopoulos
Index: Clin. Ther. 6(3) , 282-93, (1984)
Full Text: HTML
Abstract
Evaluations of the comparative efficacy and safety of hydrocortisone valerate 0.2% ointment were made in six double-blind, multicenter trials involving a total of 485 patients, 209 with atopic dermatitis and 276 with plaque psoriasis. The vasoconstrictor activity of hydrocortisone valerate 0.2% ointment was also assessed in normal subjects. Hydrocortisone valerate 0.2% ointment displayed therapeutic effects within three days. In terms of global evaluations of efficacy, hydrocortisone valerate was more effective than vehicle and was comparable to other intermediate or moderate potency corticosteroid ointments. The vasoconstrictor activity of hydrocortisone valerate 0.2% ointment was greater than that of other moderate potency ointments.
Related Compounds
Related Articles:
Topical corticosteroid compounding: effects on physicochemical stability and skin penetration rate.
1989-11-01
[J. Am. Acad. Dermatol. 21(5 Pt 1) , 979-84, (1989)]
1985-11-01
[J. Am. Acad. Dermatol. 13(5 Pt 1) , 784-91, (1985)]
Temporal infiltration of leukocyte subsets into mouse skin inflamed with phorbol ester.
1992-11-01
[Agents Actions 37(3-4) , 260-7, (1992)]
Contact hypersensitivity to tixocortol pivalate.
1998-05-01
[J. Am. Acad. Dermatol. 38(5 Pt 1) , 691-5, (1998)]
A dermatitis-eosinophilia syndrome. Treatment with methylprednisolone pulse therapy.
1984-12-01
[Arch. Dermatol. 120(12) , 1595-7, (1984)]